CRISPR Therapeutics AG (CRSP) Invested Capital (2025 - 2026)

CRISPR Therapeutics AG has disclosed Invested Capital across 2 years of filings, most recently posting $2.3 billion for Q2 2026.

• In Q2 2026, Invested Capital changed N/A year-over-year to $2.3 billion; the TTM figure through Jun 2026 stood at $2.3 billion (changed N/A YoY), while the FY2025 annual figure was $1.9 billion, changed N/A from the prior year.
• Invested Capital came in at $2.3 billion for Q2 2026 at CRISPR Therapeutics AG, down from $2.4 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.4 billion in Q1 2026 to a low of $1.9 billion in Q4 2025.